BioLargo's market cap is currently ―. The company's EPS TTM is $-0.012; its P/E ratio is -25.59; BioLargo is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 4.37M	$ 2.67M	$ 1.45M	$ 3.55M	$ -3.79M
Gross Profit	$ 1.96M	$ 1.50M	$ 819.00K	$ 1.81M	$ -4.92M
EBIT	$ -1.00M	$ -1.50M	$ -1.61M	$ 4.13M	$ -1.40M
EBITDA	$ -913.00K	$ -1.42M	$ -1.53M	$ 4.15M	$ -1.38M
Net Income Common Stockholders	$ -729.00K	$ -1.20M	$ -1.33M	$ 3.83M	$ 2.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.54M	$ 3.04M	$ 3.58M	$ 3.26M	$ 1.85M
Total Assets	$ 8.21M	$ 6.54M	$ 6.68M	$ 6.65M	$ 4.86M
Total Debt	$ 1.40M	$ 1.15M	$ 1.18M	$ 1.21M	$ 1.21M
Net Debt	$ -2.14M	$ -1.89M	$ -2.39M	$ -2.05M	$ -644.00K
Total Liabilities	$ 4.00M	$ 2.73M	$ 2.56M	$ 3.10M	$ 2.85M
Stockholders Equity	$ 6.84M	$ 7.07M	$ 7.37M	$ 6.38M	$ 4.88M
Cash Flow	-
Free Cash Flow	$ -148.00K	$ -1.04M	$ -1.56M	$ -91.00K	$ -66.00K
Operating Cash Flow	$ -2.00K	$ -836.00K	$ -1.48M	$ -43.00K	$ 41.00K
Investing Cash Flow	$ -146.00K	$ -205.00K	$ -79.00K	$ -48.00K	$ -107.00K
Financing Cash Flow	$ 761.00K	$ 507.00K	$ 1.88M	$ 1.51M	$ 613.00K

Currency in USD

BioLargo Earnings and Revenue History

Income Statement >

BioLargo Debt to Assets

Balance Sheet >

BioLargo Cash Flow

Cash Flow >

BioLargo Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing